J
Jean-Claude Florent
Researcher at Curie Institute
Publications - 72
Citations - 1405
Jean-Claude Florent is an academic researcher from Curie Institute. The author has contributed to research in topics: Prodrug & Chiral pool synthesis. The author has an hindex of 20, co-authored 72 publications receiving 1294 citations. Previous affiliations of Jean-Claude Florent include PSL Research University & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation
TL;DR: Data showed that minor alteration in the chemical structure of the heterocyclic ring and its relative orientation with regard to the two phenyl rings of CA4 could dramatically influence the tubulin binding properties.
Journal ArticleDOI
Mechanism of Shiga Toxin Clustering on Membranes
Weria Pezeshkian,Weria Pezeshkian,Haifei Gao,Haifei Gao,Senthil Arumugam,Senthil Arumugam,Ulrike Becken,Patricia Bassereau,Patricia Bassereau,Jean-Claude Florent,John Hjort Ipsen,Ludger Johannes,Julian C. Shillcock +12 more
TL;DR: Line tension due to curvature, height, or compositional mismatch, and lipid or solvent depletion cannot drive the clustering of Shiga toxin molecules, and this force is predicted to operate between manufactured nanoparticles providing they are sufficiently rigid and tightly bound to the plasma membrane, thereby suggesting a route for the targeting of nanoparticles to cells for biomedical applications.
Journal ArticleDOI
Shiga Toxin‐Mediated Retrograde Delivery of a Topoisomerase I Inhibitor Prodrug
Abdessamad El Alaoui,Frédéric Schmidt,Mohamed Amessou,Marianne Sarr,Didier Decaudin,Jean-Claude Florent,Ludger Johannes +6 more
Journal ArticleDOI
Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2
Renaud Prudent,Virginie Moucadel,Chi-Hung Nguyen,Caroline Barette,Frédéric Schmidt,Jean-Claude Florent,Laurence Lafanechère,Céline F. Sautel,Eve Duchemin-Pelletier,Elodie Spreux,Odile Filhol,Jean-Baptiste Reiser,Claude Cochet +12 more
TL;DR: The identification of ellipticine derivatives and their tetracyclic angular benzopyridoindole analogues as novel ATP-competitive inhibitors of the protein kinase CK2 showed that these compounds have a good pharmacologic profile, causing a marked inhibition of CK2 activity associated with cell cycle arrest and apoptosis in human cancer cells.
Journal ArticleDOI
Pharmacological inhibition of LIM Kinase stabilizes microtubules and inhibits neoplastic growth
Renaud Prudent,Emilie Vassal-Stermann,Chi Hung Nguyen,Catherine Pillet,Anne Martinez,Chloé Prunier,Caroline Barette,Emmanuelle Soleilhac,Odile Filhol,Anne Beghin,Glaucio Valdameri,Stéphane Honoré,Samia Aci-Sèche,David S. Grierson,Juliana Antonipillai,Rong Li,Attilio Di Pietro,Charles Dumontet,Diane Braguer,Jean-Claude Florent,Stefan Knapp,Ora Bernard,Laurence Lafanechère +22 more
TL;DR: Pyr1 inhibition of LIM kinase caused a microtubule-stabilizing effect, which was independent of any direct effects on the actin cytoskeleton, and retained its activity in multidrug-resistant cancer cells that were resistant to conventional micro Tubule-targeting agents.